4.7 Review

LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway

Journal

Publisher

ELSEVIER
DOI: 10.1016/j.bbadis.2018.03.005

Keywords

Pancreatic cancer; Long noncoding RNA; UCA1; YAP; The Hippo pathway

Funding

  1. National Natural Science Foundation of China [81672402, 81472333]
  2. Provincial Natural Science Foundation of Jiangsu, China [BK20171305]
  3. Research Programs of Jiangsu Provincial Commission of Health and Family Planning, China [H201434]
  4. Six one Project Research Projects of High-level Medical Personnel of Jiangsu Province [LGY2016054]
  5. Six Talents Peak High-level Talent Selection and Training Project of Jiangsu Province [2014-WSW-038]
  6. Science and Technology Support Program Project of Zhenjiang, China [SH2014024]
  7. Jiangsu Provincial Medical Talent Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Province [ZDRCC2016026]
  8. Qing Lan Project of Jiangsu Provincial Education Department

Ask authors/readers for more resources

Although overexpression of the long non-coding RNA (IncRNA) UCA1 has been implicated in several human cancers, its biological function in pancreatic cancer remains to be clarified. In this study, we reported that UCA1 expression was significantly increased in pancreatic cancer tissues and correlated with clinicopathological features, tumor stage, and poorer patient outcome. We further showed that UCA1 promoted cell migration and invasion of pancreatic cancer cells. Importantly, we found that UCA1 overexpression inhibited YAP phosphorylation, and increased YAP expression. Mechanistically, UCA1 interacted with MOB1, Lats1, and YAP, forming shielding composites. Moreover, we demonstrated that UCA1 increased YAP nuclear localization and stabilization, and improved TEAD luciferase activity. In turn, YAP promotes UCA1 expression. Collectively, the present study provides insights into the mechanistic regulation of UCA1 promoting pancreatic cancer progression through the Hippo signaling pathway. UCA1 may serve as a candidate biomarker for poor prognosis and a target for new pancreatic cancer therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available